EEF1AKMT3: A Potential Drug Target and Biomarker for Proteasome-Mediated diseases

Target Name: EEF1AKMT3

NCBI ID: G25895

EEF1AKMT3: A Potential Drug Target and Biomarker for Proteasome-Mediated diseases

Introduction

Proteasome-mediated diseases are a class of diseases characterized by the accumulation of misfolded or damaged proteins in the cytosol of cells. These diseases, including neurodegenerative disorders, cancer, and Inflammatory diseases, have a significant impact on human health and have a high economic burden due to lost productivity and healthcare costs. Understanding the regulation of protein homeostasis is crucial for the development of effective therapies for these diseases. One of the key players in this process is the protein-lysine methyltransferase (PMT), a enzyme that plays a crucial role in the regulation of protein folding and quality control. In this article, we will explore the EEF1AKMT3 (Protein-lysine methyltransferase METTL21B) as a potential drug target and biomarker for proteasome-mediated diseases.

The Role of PMT in Protein Homeostasis

Proteasomes are large organelles responsible for the degradation of damaged or misfolded proteins. PMT is a critical enzyme that participates in the process of protein folding and modification, thereby ensuring the quality and stability of the proteins that are degraded by the proteasome. PMT uses a unique mechanism of action, where it adds a methyl group to the lysine residue of the target protein, thereby altering its stability and accessibility. This process is reversible and allows for the rescue of misfolded proteins that could otherwise be damaged or catastrophic for the cell.

In summary, PMT plays a pivotal role in regulating protein homeostasis, ensuring that only stable and correctly-folded proteins are degraded by the proteasome. The dysregulation of PMT has been implicated in a number of proteasome-mediated diseases, including neurodegenerative disorders, cancer, and Inflammatory diseases.

EEF1AKMT3 as a Potential Drug Target

The identification of EEF1AKMT3 as a potential drug target is based on several factors. Firstly, EEF1AKMT3 is a highly expressed protein in human tissues, which suggests that it is a good candidate for targeting. Secondly, the function of EEF1AKMT3 is closely linked to the regulation of protein homeostasis, which is a key factor in the development and progression of many diseases. Finally, the structure and function of EEF1AKMT3 are consistent with a protein-tyrosine kinase (PTK) target, which is a common framework for drug development.

EEF1AKMT3 has been shown to play a role in the regulation of protein folding and stability, and is involved in the formation of a protein-protein interaction complex with the protein NLRP1. This interaction suggests that EEF1AKMT3 may be a useful target for interventions aimed at modulating protein homeostasis.

EEF1AKMT3 as a Biomarker

The dysregulation of PMT has been implicated in the development and progression of many diseases, including neurodegenerative disorders, cancer, and Inflammatory diseases. Therefore, the measurement of PMT activity or its levels may be an attractive biomarker for these diseases.

EEF1AKMT3 has been shown to be involved in the regulation of protein homeostasis, which is a key factor in the development and progression of many diseases. By modulating the levels or activity of PMT, this enzyme may be a useful target for the development of therapies aimed at treating these diseases.

Conclusion

In conclusion, EEF1AKMT3 is a protein-lysine methyltransferase that plays a crucial role in the regulation of protein homeostasis. Its dysregulation has been implicated in the development and progression of many diseases, including neurodegenerative disorders, cancer, and Inflammatory diseases. Therefore, EEF1AKMT3 is a potential drug target and biomarker for these diseases. Further studies are needed to fully understand the role of this enzyme in

Protein Name: EEF1A Lysine Methyltransferase 3

Functions: Protein-lysine methyltransferase that selectively mono-, di- and trimethylates 'Lys-165' of the translation elongation factors EEF1A1 and EEF1A2 in an aminoacyl-tRNA and GTP-dependent manner. EEF1A1 methylation by EEF1AKMT3 is dynamic as well as inducible by stress conditions, such as ER-stress, and plays a regulatory role on mRNA translation

More Common Targets